C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/21/2002	US20020174452 Modifying lignan content in plants by transforming plants with vectors containing a DNA sequence encoding one or more proteins integral to the phenylpropanoid pathway leading to G-lignan formation
11/21/2002	US20020174448 Transgenic expression from a SOCS-3 promoter in vertebrate cells
11/21/2002	US20020174447 Performing matings between first parent strain carrying mutation in Alzheimer's disease gene and a series of parent strains each containing one of a series of genetic variations to produce a series of test progeny, screening
11/21/2002	US20020174446 Identification of genes involved in alzheimer's disease using drosophila melanogaster
11/21/2002	US20020173643 Fusion protein delivery system and uses thereof
11/21/2002	US20020173642 Human gastric cancer antigen gene and gastric cancer antigen protein
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173636 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of diabetes, dietetics, eating disorders, and cachexia
11/21/2002	US20020173635 Secreted expressed sequence tags (sESTs)
11/21/2002	US20020173628 Chimeric IL-10 proteins and uses thereof
11/21/2002	US20020173627 TIE-2 ligands, methods of making and uses thereof
11/21/2002	US20020173626 Fusion protein for use in the diagnosis, prevention and treatment of liver disorders
11/21/2002	US20020173625 Hybrid polypeptide for use in the treatment and prevention of allergic disorders
11/21/2002	US20020173624 Polypeptide for use in treatment and prevention of liver, nervous system and glandular disorders
11/21/2002	US20020173623 Mammalian cytokines; receptors; related reagents and methods
11/21/2002	US20020173622 Tsg101-GAGp6 interaction and use thereof
11/21/2002	US20020173621 Generation of preferential fusion protein; obtain cell, transform with expression vector coding fusion polypeptide, propagate, express vector, recover fusion protein
11/21/2002	US20020173620 Bifunctional fusion proteins formed from hirudin and TAP
11/21/2002	US20020173618 SSTR1-selective analogs
11/21/2002	US20020173479 Administering genes to suppress cancer
11/21/2002	US20020173475 Methods to inhibit viral replication
11/21/2002	US20020173474 Methods & materials involving dimerization-mediated regulation of biological events
11/21/2002	US20020173465 Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments
11/21/2002	US20020173463 Isolated nucleic acids; and antibodies
11/21/2002	US20020173462 Fibrinogen binding protein
11/21/2002	US20020173461 Methods for enhancing the efficacy of cancer therapy
11/21/2002	US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002	US20020173459 Isolated peptide; antibodies; genetic engineering
11/21/2002	US20020173458 Polypeptides; genetic engineering
11/21/2002	US20020173457 Polypeptides
11/21/2002	US20020173455 23927, a novel human ion channel
11/21/2002	US20020173453 Administering mammals a bone morphogenic protein, transforming growth factor, fibroblast growth factor
11/21/2002	US20020173449 O-superfamily conotoxin peptides
11/21/2002	US20020173445 Selective androgen receptor modulators and methods for their identification, design and use
11/21/2002	US20020173049 Controlling protein levels in eucaryotic organisms
11/21/2002	US20020173039 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/21/2002	US20020173031 Amplification or reduction of drug resistance in bacteria, yeast, plant of mamalian cells; obtain cell, adjust adenosine triphosphate gradient, monitor drug resistance
11/21/2002	US20020173030 Lenitiviral packaging system for use as tool in genetic engineering
11/21/2002	US20020173029 Chemical structure for use in the prevention and treatment of viral infections
11/21/2002	US20020173027 Secreted salivary zsig63 polypeptide
11/21/2002	US20020173026 Survivin-interacting proteins and use thereof
11/21/2002	US20020173024 Nucleotide sequences coding polypeptide for use in the prevention of freezing damage to tissue during surgery associated with freezing tumors
11/21/2002	US20020173017 Wooden leg gene, promoter and uses thereof
11/21/2002	US20020173007 Human chemokine polypeptides
11/21/2002	US20020173006 Generating chimeric zinc finger protein; obtain nucleotide sequences coding chimeric protein, transform cells, express nucleotide sequences, recover protein
11/21/2002	US20020173005 Nucleotide sequences coding polypeptide for use in the treatment of thrombosis
11/21/2002	US20020173004 Nucleotide sequences coding transport protein for use in the treatment of nervous system disorders
11/21/2002	US20020173003 Directed evolution of microorganisms
11/21/2002	US20020173002 Polypeptide for use in the diagnosis, prevention, and treatment of cancer, inflammation, and disorders associated with retinoid metabolism
11/21/2002	US20020173001 Variant TLR4 nucleic acid and uses thereof
11/21/2002	US20020173000 Nucleotide sequences coding polypeptide for use in treatment of alzeihmer's, parkinson, muscular, epilepsy, stroke, heart defects, amyotrophic lateral sclerosis, multiple sclerosis, inflammation, pain, cancer, and dietetic disorders
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172998 32612, a novel human peptide transporter and uses therefor
11/21/2002	US20020172996 Nucleotide sequences coding protein for use in the treatment, diagnosis and prevention of gaucher's, and liver disorders
11/21/2002	US20020172995 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/21/2002	US20020172994 Nucleotide sequences coding polypeptides for use in the treatment of inflammation, tumors, arthritis, asthma, viral and inflammatory bowel diseases
11/21/2002	US20020172990 Cyclin dependent kinase 5 phosphorylation of disabled 1 protein
11/21/2002	US20020172986 23228, a novel human tetraspanin family member and uses thereof
11/21/2002	US20020172985 Cassette for expressing a Toxoplasma gondii P30 protein
11/21/2002	US20020172984 Modulation of sctivity of transmembrane ligand; obtain sample containing tyrosine kinase, incubate with ligand, monitor bological activity, compare to control, adjustment in biological activity indicates modulator
11/21/2002	US20020172982 Glycoprotein for use in diagnosis and treatment of human sexual disorders
11/21/2002	US20020172977 Forming a prion; obtain mutant prion, bind linker, monitor activity of prion
11/21/2002	US20020172976 P. gingivalis polynucleotides and uses thereof
11/21/2002	US20020172962 Generation of nucleotide sequence ligands; obtain nucleotide sequences mixture, separate nucleotide sequences, amplify nucleotide sequences, incubate with modulator, detect adjustment in binding activity
11/21/2002	US20020172959 Compositions and methods relating to lung specific genes and proteins
11/21/2002	US20020172957 Nucleotide squences coding preferential polypepttide for use in the diagnosis, prevention, treatment and classification of lung cancer
11/21/2002	US20020172952 Compositions and methods for the therapy and diagnosis of lung cancer
11/21/2002	US20020172951 Determnine the concentration of hysteresis proteins in sample; obtain protein sample, freeze, heat, monitor ice crystal grain adjustment, detect hysteresis proteins in solution
11/21/2002	US20020172939 DNA, RNA, amino acid sequences for detecting antibodies against retroviruses which are associated with immunodeficiency diseases; diagnosis
11/21/2002	US20020172718 Fibrinogen and fibronectin-containing solution is treated with a precipitating formulation which comprises components that modify solubility of fibrinogen and/or fibronectin, so that in a single-step precipitation, precipitate is formed
11/21/2002	US20020172691 Use of a bacterial vaccinating preparation developed from a given bacterium of Bordetella genus for the preparation of protective antigen for man and animals against infections and toxic effects caused by bacterium of Bordetella genus
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172685 For therapy of mycobacterial disease is selected from the group consisting of tuberculosis and Crohn's disease; vaccines
11/21/2002	US20020172684 Useful in therapy, diagnosis, and prophylaxis of tuberculosis; vaccines
11/21/2002	US20020172683 Used for therapy of viral pathologies, such as those due to HIV-1 or HIV-2 infections, for screening compounds
11/21/2002	US20020172682 Using heat shock proteins to increase immune response
11/21/2002	US20020172680 Diagnosis of metastatic cancer by the mts-1 gene
11/21/2002	US20020172679 Treatment of inflammatory bowel disease by inhibiting binding and/or signalling through alpha4beta7 and its ligands and MAdCAM
11/21/2002	US20020172678 For regulating cellular proliferation and chemotaxis
11/21/2002	US20020172674 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth
11/21/2002	US20020172671 CAIP-like gene family
11/21/2002	US20020172660 For therapy of cancer, viral infections
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447574A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
11/21/2002	CA2447564A1 Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
11/21/2002	CA2447518A1 Therapeutic use of rank antagonists
11/21/2002	CA2447431A1 Inhibitors of receptor activator of nf-kb and uses thereof
11/21/2002	CA2447118A1 Method and compositions for inhibiting thrombin-induced coagulation
11/21/2002	CA2447110A1 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis
11/21/2002	CA2447032A1 Kinetic assay
11/21/2002	CA2447017A1 Moraxella(branhamella) catarrhalis antigens
11/21/2002	CA2446991A1 Agents that regulate apoptosis
11/21/2002	CA2446953A1 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002	CA2446867A1 Global analysis of protein activities using proteome chips
11/21/2002	CA2446859A1 Transgenic animal model of bone mass modulation
11/21/2002	CA2446839A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002	CA2446821A1 Hbm variants that modulate bone mass and lipid levels
11/21/2002	CA2446720A1 High density lipoprotein-reactive peptides
11/21/2002	CA2446589A1 Methods for treating cancer
11/21/2002	CA2446582A1 Reagents and methods for modulating dkk-mediated interactions

1 ... 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 ... 2916